Keyphrases
A1 Receptor
100%
Glucagon-like
100%
G Protein Signaling
100%
Signaling Bias
100%
Ligand-receptor Binding
28%
Chimera
28%
No Significant Difference
14%
Receptor Activation
14%
Small Molecules
14%
Clinically Significant
14%
Glycemic Control
14%
Insulin
14%
Cell Growth
14%
Adverse Effects
14%
Type 2 Diabetes Mellitus (T2DM)
14%
Dissociation Constant
14%
Receptor Antagonist
14%
Therapeutic Agents
14%
Yeast Strains
14%
G Protein Coupling
14%
Exenatide
14%
Molecular Events
14%
Liraglutide
14%
Prolonged Use
14%
Coupling Preference
14%
Incomplete Understanding
14%
Exendin-3
14%
G Protein Selectivity
14%
Allosteric Compounds
14%
Glucagon Receptor
14%
Biochemistry, Genetics and Molecular Biology
G Protein
100%
Glucagon-Like Peptide 1 Receptor
100%
Signaling Protein
100%
Small Molecule
14%
Receptor Antagonist
14%
Cell Growth
14%
Glycemic Control
14%
Dissociation Constant
14%
Glucagon Receptor
14%
Liraglutide
14%
Medicine and Dentistry
Glucagon Like Peptide 1 Receptor
100%
Guanine Nucleotide Binding Protein
100%
Receptor
42%
Side Effect
14%
Maturity Onset Diabetes of the Young
14%
Glycemic Control
14%
Receptor Antagonist
14%
Cell Growth
14%
Exenatide
14%
Therapeutic Agent
14%
Liraglutide
14%
Glucagon Receptor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Guanine Nucleotide Binding Protein
100%
Glucagon-Like Peptide 1 Receptor
100%
Receptor
42%
Non Insulin Dependent Diabetes Mellitus
14%
Side Effect
14%
Receptor Antagonist
14%
Exendin 4
14%
Liraglutide
14%
Glucagon Receptor
14%
Neuroscience
Glucagon-Like Peptide 1 Receptor
100%
G Protein
100%
Receptor
42%
Receptor Antagonist
14%
Exenatide
14%
Cell Growth
14%
Glucagon Receptor
14%
Liraglutide
14%